Opinion

Video

Limiting Transmission of RSV

Author(s):

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, outlines evidence-based measures that can be implemented to prevent or minimize the transmission of RSV.

Video content above is prompted by the following question:

  • What evidence-based measures can be implemented for patients to prevent or minimize the transmission of RSV?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Related Content
Infectious viruses such as respiratory syncytial virus (RSV) causing respiratory infections - Image credit: Artur | stock.adobe.com
June 6th 2025

Meta-Analysis Evaluates RSV Viral Load and Symptom Kinetics

Kennedy Ferruggia, Assistant Editor
MEDcast logo
July 1st 2024

Key Considerations for the Effective Utilization of RSV Vaccines

Ashley Pugh, PharmD, BCACP Lauren B. Angelo, PharmD, MBA
RSV vaccine vial with syringe - Respiratory syncytial virus shot -Image credit: MargJohnsonVA | stock.adobe.com
May 19th 2025

Study Reveals Safety and Effectiveness of RSV Vaccine for Older Adults

Kennedy Ferruggia, Assistant Editor
Carefully Consider Optimal Timing of RSV Vaccination in Older Adults
May 13th 2025

Carefully Consider Optimal Timing of RSV Vaccination in Older Adults

Lisa Rosenberg, PharmD, BCGP
RSV vaccine vial with syringe - Respiratory syncytial virus shot - Image credit: MargJohnsonVA | stock.adobe.com
May 9th 2025

Study: RSV Vaccine Response in Lung Transplant Recipients

Kennedy Ferruggia, Assistant Editor
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
May 1st 2025

Adult RSV-ARI Linked to Higher Death Risk and Health Care Costs

Kennedy Ferruggia, Assistant Editor